masoprocol has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arshad, S; Azhar, S; Bittner, S; Cortez, Y; Dong, D; Dulay, H; Han, L; Kraemer, FB; Shen, WJ | 1 |
| Hwang, JK; Jo, K; Kim, D; Lee, MS | 1 |
2 other study(ies) available for masoprocol and Obesity
| Article | Year |
|---|---|
Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).
Topics: Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Hyperlipidemias; Inflammation; Insulin Resistance; Larrea; Lipogenesis; Male; Masoprocol; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress | 2019 |
Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.
Topics: Adiposity; AMP-Activated Protein Kinases; Animals; Diet; Dietary Fats; Fatty Liver; Hepatocytes; Insulin; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Triglycerides; Weight Gain | 2010 |